Login to Your Account


Thinking 'broadly and strategically'
Four months ago, Takeda Pharmaceutical Co. Ltd. took an option to develop and commercialize MGD010, developed in-house by Macrogenics Inc. that uses its DART technology to simultaneously engage the B-cell surface proteins CD32B and CD79B, targeting autoimmune diseases.more »

Our Habitat for All Things Science
2014 Lasker Award again goes for therapeutic brain stimulation

Alim Louis Benabid and Mahlon R. DeLong are the recipients of the 2014 Lasker~DeBakey Clinical Medical Research Award "for Development of Deep Brain Stimulation of the Subthalamic Nucleus," a treatment for patients with Parkinson's disease who no longer respond to treatment with the drug L-dopa.

The Albert Lasker Basic Medical Research Award was shared by Kazutoshi Mori and Peter Walter for their discoveries about the unfolded protein response, a cellular quality control system.

READ MORE »

Opinion


Partners in Focus